SignalPET Elevates Leadership Team and Announces Strategic Expansion
14 août 2024 08h00 HE
|
SignalPET
Dallas, TX, Aug. 14, 2024 (GLOBE NEWSWIRE) -- SignalPET, a medical technology innovator in the veterinary industry, proudly announces two pivotal leadership changes, bolstering the launch of a...
SignalPET Announces New Initiative to Empower Veterinary Graduates
16 juil. 2024 08h00 HE
|
SignalPET
Dallas, TX, July 16, 2024 (GLOBE NEWSWIRE) -- SignalPET, a leading veterinary technology company, just announced a groundbreaking new Graduate Incentive program designed to nurture the next...
SignalPET Has Launched a Rapid Veterinary Radiology Service, SignalSTAT, combining AI and Human Oversight to Improve Speed of Care & Patient Outcomes
09 janv. 2024 08h00 HE
|
SignalPET
Dallas, TX, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Veterinary radiology company, SignalPET has launched their new product, SignalSTAT, which seamlessly blends cutting-edge AI technology with human...
New to The Street Re-signs PetVivo Holdings, Inc. for another 12-Month TV Media Series; Agreement Includes Commercials and Billboard Ads
20 déc. 2023 09h30 HE
|
FMW Media Works Corp
New to The Street Re-signs PetVivo Holdings, Inc. for another 12-Month TV Media Series; Agreement Includes Commercials and Billboard Ads
AAHA Announces Enhanced Digital Benchmarking Platform – Now Free for All Members
08 déc. 2023 14h48 HE
|
American Animal Hospital Association
Lakewood, CO, Dec. 08, 2023 (GLOBE NEWSWIRE) -- The American Animal Hospital Association (AAHA) is proud to partner with Chewy Health to provide its comprehensive analytics platform, AAHA...
Research Proves Assisi Animal Health’s Calmer Canine® Clinically Resolves Canine Separation Anxiety
11 janv. 2022 11h23 HE
|
Assisi Animal Health
New York, NY, Jan. 11, 2022 (GLOBE NEWSWIRE) -- A recent study conducted by North Carolina State University conclusively demonstrates that Assisi Animal Health’s targeted pulsed electromagnetic...
LexaGene Closes Multiple MiQLab Sales
03 déc. 2021 07h45 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Dec. 03, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Finalizes Design of Pneumonia Panel
01 nov. 2021 07h45 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
LexaGene’s MiQLab™ System Selected to be a Best in Show Spotlight at the 47th Annual Industry Petcare Innovation Summit
27 oct. 2021 07h45 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
LexaGene Reports on Recent Veterinary Trade Shows
30 sept. 2021 07h45 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a commercial molecular diagnostics company selling a...